Treatment for Atrial Fibrillation

Phase-Based Progress Estimates
WakeMed Health and Hospitals, Raleigh, NCAtrial Fibrillation
20 - 85
All Sexes
What conditions do you have?

Study Summary

This trial looks at how CardiaMend and amiodarone can help prevent atrial fibrillation after heart surgery.

Eligible Conditions
  • Post-operative Atrial Fibrillation

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Through discharge, an average of 2 weeks

Week 2
Additional Hospital Time Required Due to Atrial Fibrillation/Flutter
Post Operative Atrial Fibrillation

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

0 Treatment Group

30 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · Phase 4

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through discharge, an average of 2 weeks

Who is running the clinical trial?

WakeMed Health and HospitalsLead Sponsor
5 Previous Clinical Trials
3,623 Total Patients Enrolled
Helios Cardio IncUNKNOWN
Judson B Williams, MDPrincipal InvestigatorWakeMed Health and Hospitals

Eligibility Criteria

Age 20 - 85 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: